Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration

References

• Amorij JP, Kersten GF, Saluja V, et al. (2012). Towards tailored vaccine delivery: needs, challenges and perspectives. J Control Release 161:363–76.
   PubMed Web of Science ®Google Scholar
• Arthanari S, Mani G, Peng MM, et al. (2016). Chitosan-HPMC-blended microspheres as a vaccine carrier for the delivery of tetanus toxoid. Artif Cells Nanomed Biotechnol 44:517–23.
   PubMed Web of Science ®Google Scholar
• Awad F, Forrester A, Baylis M, et al. (2015). Immune responses and interactions following simultaneous application of live Newcastle disease, infectious bronchitis and avian Metapneumovirus vaccines in specific-pathogen-free chicks. Res Vet Sci 98:127–33.
   PubMed Web of Science ®Google Scholar
• Barakat NS, Almurshedi AS. (2011). Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation. J Pharm Pharmacol 63:169–78.
   PubMed Web of Science ®Google Scholar
• Barhate G, Gautam M, Gairola S, et al. (2014). Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment. J Pharm Sci 103:3448–56.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Cai H, Yin B. (2013). Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery. Int J Pharm 454:425–34.
   PubMed Web of Science ®Google Scholar
• Dai CX, Kang H, Yang WQ, et al. (2015). O-2′-Hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live newcastle disease vaccine. Carbohyd Polym 130:180–9.
   Web of Science ®Google Scholar
• Di Giacomo S, Quattrocchi V, Zamorano P. (2015). Use of adjuvants to enhance the immune response induced by a DNA vaccine against Bovine herpesvirus-1. Viral Immunol 28:343–6.
   PubMed Web of Science ®Google Scholar
• Flingai S, Czerwonko M, Goodman J. (2013). Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Front Immunol 4:354–66.
   PubMed Web of Science ®Google Scholar
• Fowler V, Robinson L, Bankowski B. (2012). A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Antiviral Res 94:25–34.
   PubMed Web of Science ®Google Scholar
• Gavini E, Hegge AB, Rassu G, et al. (2006). Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm 307:9–15.
   PubMed Web of Science ®Google Scholar
• Huang YC, Huang JC, Cai JH, et al. (2015). Carboxymethyl chitosan/clay nanocomposites and their copper complexes: fabrication and property. Carbohyd Polym 134:390–7.
   PubMed Web of Science ®Google Scholar
• Islam MA, Firdous J, Choi YJ, et al. (2012). Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review. Int J Nanomed 7:6077–93.
   PubMed Web of Science ®Google Scholar
• Jankovic D, Feng CG. (2015). CD4(+) T cell differentiation in infection: amendments to the Th1/Th2 axiom. Front Immunol 6:198–200.
   PubMed Web of Science ®Google Scholar
• Jin Z, Li W, Cao HW, et al. (2013). Antimicrobial activity and cytotoxicity of N-2-HACC and characterization of nanoparticles with N-2-HACC and CMC as a vaccine carrier. Chem Eng J 221:331–41.
   Web of Science ®Google Scholar
• Kapczynski DR, Afonso CL, Miller PJ. (2013). Immune responses of poultry to Newcastle disease virus. Dev Comp Immunol 41:447–53.
   PubMed Web of Science ®Google Scholar
• Khameneh B, Momen-nejad M, Tafaghodi M. (2014). In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethyl chitosan polymer. Nanomed J 1:147–54.
   Google Scholar
• Kouakou AV, Kouakou V, Kouakou C, et al. (2015). Prevalence of Newcastle disease virus and infectious bronchitis virus in avian influenza negative birds from live bird markets and backyard and commercial farms in Ivory-Coast. Res Vet Sci 102:83–8.
   PubMed Web of Science ®Google Scholar
• Liu F, Sun XJ, Fairman J, et al. (2016). A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets. Virology 492:197–203.
   PubMed Web of Science ®Google Scholar
• Manoj S, Babiuk LA. (2004). Approaches to enhance the efficacy of DNA vaccines. Crit Rev Clin Lab Sci 41:1–39.
   PubMed Web of Science ®Google Scholar
• Meerak J, Wanichwecharungruang SP, Palaga T. (2013). Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Vaccine 31:784–90.
   PubMed Web of Science ®Google Scholar
• Mohajer M, Khameneh B, Tafaghodi M. (2014). Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin. Iran J Basic Med Sci 17:722–6.
   PubMed Web of Science ®Google Scholar
• Olabode AO, Ndako JA. (2010). Use of cracked maize as a carrier for NDV4 vaccine in experimental vaccination of chickens. Virol J 7:67–72.
   PubMed Web of Science ®Google Scholar
• Pirouzmand H, Khameneh B, Tafaghodi M. (2017). Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid. Pharm Biol 55:212–7.
   PubMed Web of Science ®Google Scholar
• Rauw F, Gardin Y, Palya V, et al. (2010). The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunop 134:249–58.
   PubMed Web of Science ®Google Scholar
• Sergio AB, Myriam P, Joaquín P, et al. (2014). Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration. J Virol 11:149–60.
   Web of Science ®Google Scholar
• Sharma R, Agrawal U, Mody N. (2015). Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities. Biotechnol Adv 33:64–79.
   PubMed Web of Science ®Google Scholar
• Singh M, Briones M, Ott G, et al. (2000). Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97:811–6.
   PubMed Web of Science ®Google Scholar
• Sonia TA, Sharma CP. (2011). In vitro evaluation of N-(2-hydroxy) propyl-3-trimethyl ammonium chitosan for oral insulin delivery. Carbohyd Polym 84:103–9.
   Web of Science ®Google Scholar
• Sridhar S, Brokstad KA, Cox RJ. (2015). Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines (Basel) 3:373–89.
   PubMed Web of Science ®Google Scholar
• Talebi A, Amani A, Pourmahmod M, et al. (2015). Synbiotic enhances immune responses against infectious bronchitis, infectious bursal disease, Newcastle disease and avian influenza in broiler chickens. Vet Res Forum 6:191–7.
   PubMed Web of Science ®Google Scholar
• Thwala LN, Préat V, Csaba NS. (2017). Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes. Expert Opin Drug Del 14:23–36.
   PubMed Web of Science ®Google Scholar
• Van der Lubben IM, Kersten G, Fretz MM, et al. (2003). Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 21:1400–8.
   PubMed Web of Science ®Google Scholar
• Wu W, Perrin-Sarrado C, Ming H, et al. (2016). Polymer nanocomposites enhance S-nitrosoglutathione intestinal absorption and promote the formation of releasable nitric oxide stores in rat aorta. Nanomedicine 12:1795–803.
   PubMed Web of Science ®Google Scholar
• Xu JH, Dai WJ, Wang ZM, et al. (2011). Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumonia. Clin Vaccine Immunol 18:75–81.
   PubMed Web of Science ®Google Scholar
• Zhao K, Chen G, Shi XM, et al. (2012). Preparation and efficacy of a live Newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PLoS One 7:e53314.
   PubMed Web of Science ®Google Scholar
• Zhao K, Yang Z, Zhang XY, et al. (2014). Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine. Int J Nanomedicine 9:4609–19.
   PubMed Web of Science ®Google Scholar